Filtered By:
Management: Insurance
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 835 results found since Jan 2013.
Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry
CONCLUSIONS: In this real-world study of patients with AD, greater clinician-reported disease severity is positively correlated with higher patient-reported disease severity and lower QoL. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7473 Access Supplementary Material here Citation: Guttman-Yassky E, Bar J, Rothenberg Lausell C, et al. Do atopic dermatitis patient-reported outcomes correlate with validated investigator global assessment? Insights from TARGET-AD registry. J Drugs Dermatol. 2023;22(4):344-355. doi:10.36849/JDD.7473.PMID:37026893 | DOI:10.36849/JDD.7473
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Emma Guttman-Yassky Jonathan Bar Camille Lausell Lawrence Eichenfield Ayman Grada Katrina Abuabara M Chapman Brian Calimlim Colleen Wegzyn Amy Gamelli Whitney Krueger Breda Munoz Keith Knapp Rachel Faller Julie Crawford Jonathan Silverberg Source Type: research
Incidence of Cardiovascular Disease After Atopic Dermatitis Development: A Nationwide, Population-Based Study
CONCLUSIONS: The current study found that adult patients newly diagnosed with AD were at significantly increased risk for subsequent CVDs, suggesting the need to consider early prevention strategies for CVDs targeting patients with AD.PMID:37021508 | DOI:10.4168/aair.2023.15.2.231
Source: Allergy, Asthma and Immunology Research - April 6, 2023 Category: Allergy & Immunology Authors: Seung Won Lee Hayeon Kim Youngjoo Byun Yoo Sang Baek Cheol Ung Choi Jae Hyun Kim Kyungim Kim Source Type: research
